Korean Researchers Uncover New Clues to Enhance Chronic Myeloid Leukemia Treatment
Korean researchers have uncovered a biological mechanism that could significantly improve the efficacy of treatments for chronic myeloid leukemia .
Search results for "Targeted Cancer Drugs"
Can Daraxonrasib Reshape Pancreatic Cancer Care? Experts Weigh Promise and Limits
Pancreatic cancer remains one of the most formidable malignancies. Because early-stage disease rarely produces distinct symptoms, many cases have...
Why Stage 3 Breast Cancer Doesn’t Always Mean Immediate Surgery
“Shouldn’t it be removed as soon as possible — even a day sooner?” This reaction is common among patients and their...
Timing of Immune Cell Entry Dictates Anti-Cancer Defense in Hard-to-Treat Brain Tumors
Some immune cells surrounding a tumor actively attack it, while others create conditions that help it survive.
Novartis Halts Lu-NeoB Development After Early Clinical Data Fall Short
Novartis has discontinued the development of Lu-NeoB, an experimental cancer therapy designed to seek out tumor cells...
The Blood Cancer Decoy: Why Some Lymphoma Patients Stop Responding to Treatment
For patients diagnosed with aggressive blood cancers, receiving a proven targeted therapy offers a clear path toward a...
AI Cancer Gene Analysis and 810 Billion-Won Tech Export Lead South Korea's Top 30 Health Care R&D Achievements
The Ministry of Health and Welfare and the Korea Health Industry Development Institute announced on the 8th that they...
Qurient’s Mocaciclib Opens New Combination Frontiers for Hard-to-Treat Breast Cancer
Qurient announced on June 29 that it presented key clinical data highlighting the mechanistic advantages of its...
Muscle Loss Double-Whammy: Sarcopenia Triggers Faster Progression in Lung Cancer Patients on Immunotherapy
Muscle mass in lung cancer patients may play a decisive role in determining the success of immunotherapy.
Nasal Drug Delivery Shows Promise for Deadly Glioblastoma Brain Tumors
A new type of cancer treatment delivered through the nose, rather than by conventional injection, is gaining...